Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk. The company manufactures products in Germany for consumers seeking targeted gum health support.
2 investors
PeriVision develops the VisionOne platform, combining AI, virtual reality, and cloud technology to test and understand visual function for eye conditions such as glaucoma. Its systems target ophthalmology practices and hospitals, aiming to improve testing workflows and provide deeper clinical insight into eye diseases.
2 investors
Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status. Its lead product is CE Marked in the European Union but not FDA cleared in the United States.
2 investors
Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid. It develops devices and technology in the neurology and brain health category.
2 investors
PharmaJet develops needle-free injection systems for delivering vaccines and therapeutics, used across a range of therapeutic areas including infectious disease prevention and cancer treatment. Its reusable devices serve pharmaceutical partners and healthcare providers as an alternative to traditional needle-based delivery.
2 investors
PharOS develops and markets generic and value-added pharmaceutical products for distribution to more than 115 countries. The company employs scientists, biologists, chemists, and pharmacists focused on drug development with emphasis on customer service and product lifecycle extension.
2 investors
PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.
2 investors
Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute. The company focuses on translating scientific discoveries into clinical therapies for patients.
2 investors
Pheno Therapeutics is a clinical-stage biotech company developing GPR17 antagonists that target oligodendrocytes to promote brain repair. Its therapeutics address neurodegenerative and demyelinating disorders such as multiple sclerosis, Alzheimer's disease, ALS, Parkinson's disease, and rare leukodystrophies.
2 investors
Pheon Therapeutics develops targeted oncology treatments, focusing on antibody-drug conjugates (ADCs) for cancer therapy.
2 investors
Philduct is a Japanese oral-tech company that develops DPEARL, a 3D-printed clear aligner orthodontic service, along with remote dental consultation and digital dentistry services. It operates a dental technology R&D lab and targets consumers seeking affordable preventive oral healthcare in Japan.
2 investors
PhiTech is a TechBio company that develops AI-powered multi-omics diagnostic platforms for rare diseases and hereditary cancers. The company serves hospitals, laboratories, and pharmaceutical companies seeking to improve diagnosis and treatment decisions for complex genetic conditions.
2 investors
Phycin develops engineered growth factors designed for higher stability and performance, including a thermostable recombinant basic fibroblast growth factor (bFGF) that remains active for 21+ days at 37°C. Its products target researchers and clinicians working in regenerative medicine, cell culture, and related life science applications.
2 investors
Pictor Diagnostics develops a proteomics platform that enables researchers, diagnostics manufacturers, clinical labs, and veterinary clinics to perform multi-marker protein testing across diverse sample types. The platform combines an affordable instrument and assays that integrate into existing lab workflows without requiring specialized equipment or training.
2 investors
Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
2 investors
Pixelgen develops DNA-based visualization technology for cell-surface proteomics, enabling nanoscale spatial analysis of immune cell proteins for precision medicine and translational research. The company's Proximity Network Assay platform supports applications in immunology, hematology, and cell therapy diagnostics and therapeutics.
2 investors
IXI (Pixie Ray) develops adaptive eyewear with autofocusing lenses that track the wearer's eye movements to adjust focus for near or far vision. The glasses combine optical technology for vision correction with conventional frame designs.
2 investors
Plasmapp develops plasma-based technologies and products for medical applications, including sterilization solutions. The company sells its products internationally, exporting to around 50 countries.
2 investors
Develops a smartphone-based blood test that uses phone camera image analysis and cloud computing to screen patients for cardio, metabolic and renal (CMR) disease risk. Aims to improve access to diagnostic testing and early identification of people at high risk of disease.
2 investors
A healthcare company that uses smartphone imaging and cloud computing to identify individuals at high risk of cardio-metabolic and renal diseases, making diagnostic screening more accessible.
2 investors
Pointer builds predictive software for veterinary care that analyzes medical history, breed, environment, and lifestyle to forecast disease risk in dogs and recommend preventive treatments. The platform enables veterinarians and pet owners to detect health issues before clinical symptoms appear.
2 investors
Polares Medical is a medical device company developing a device for treating mitral valve regurgitation.
2 investors
POLYTECH Health & Aesthetics is a German manufacturer of silicone breast and body implants used in breast augmentation, reconstruction, and body contouring procedures. The company supplies over 2,000 implant options to patients and surgeons and operates in more than 90 countries.
2 investors
Positrigo develops functional imaging technology to make diagnostic and clinical imaging scalable and accessible globally. The company serves researchers and clinicians who use imaging for disease diagnostics, treatment monitoring, and therapeutic development.
2 investors